BLUE - Bluebird bio Inc
IEX Last Trade
0.5624
-0.030 -5.334%
Share volume: 10,443,497
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.59
-0.03
-5.06%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-09 | 2022-08-04 | 2022-11-07 | 2023-03-29 | 2023-05-09 | 2023-08-08 | 2023-11-07 | |
| Assets | ||||||||
| Total Assets | 491.071 M | 573.592 M | 520.098 M | 554.902 M | 692.736 M | 663.393 M | 613.608 M | |
| Current Assets | 254.917 M | 167.458 M | 160.438 M | 199.488 M | 351.071 M | 287.977 M | 247.076 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 3.809 M | 13.642 M | 20.969 M | |
| Other Current Assets | 43.329 M | 34.949 M | 20.805 M | 19.161 M | 29.005 M | 29.032 M | 28.814 M | |
| Short Term Investments | 43.329 M | 34.949 M | 20.805 M | 19.161 M | 29.005 M | 29.032 M | 28.814 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 23.000 M | |
| Current Cash | 211.588 M | 132.509 M | 139.633 M | 180.327 M | 318.257 M | 245.303 M | 174.293 M | |
| Total Non-current Assets | 236.154 M | 406.134 M | 359.660 M | 355.414 M | 341.665 M | 375.416 M | 366.532 M | |
| Property Plant Equipment | 11.234 M | 14.566 M | 11.535 M | 9.362 M | 8.718 M | 10.227 M | 9.972 M | |
| Other Assets | 52.328 M | 52.550 M | 52.388 M | 52.128 M | 51.535 M | 51.204 M | 50.829 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 4.868 M | 5.613 M | 5.490 M | 5.368 M | |
| Goodwill | 5.646 M | 5.646 M | 5.646 M | 5.646 M | 5.646 M | 5.646 M | 5.646 M | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 491.071 M | 573.592 M | 520.098 M | 554.902 M | 692.736 M | 663.393 M | 613.608 M | |
| Total liabilities | 227.812 M | 393.476 M | 361.241 M | 358.559 M | 337.996 M | 374.374 M | 391.072 M | |
| Total current liabilities | 142.892 M | 148.861 M | 126.727 M | 128.237 M | 115.933 M | 135.016 M | 158.957 M | |
| Accounts Payable | 28.350 M | 24.865 M | 18.622 M | 25.092 M | 19.235 M | 10.894 M | 19.852 M | |
| Other liabilities | 92.000 K | 93.000 K | 92.000 K | 92.000 K | 92.000 K | 92.000 K | 92.000 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 92.000 K | 93.000 K | 92.000 K | 92.000 K | 92.000 K | 92.000 K | 92.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 263.259 M | 180.116 M | 158.857 M | 196.343 M | 354.740 M | 289.019 M | 222.536 M | |
| Common stock | 73.688 M | 73.767 M | 81.543 M | 85.342 M | 102.920 M | 108.685 M | 109.098 M | |
| Retained earnings | -3.842 B | -3.942 B | -4.019 B | -3.987 B | -3.965 B | -4.038 B | -4.110 B |